Targeted immunoconjugates

Details for Australian Patent Application No. 2010285071 (hide)

Owner Roche Glycart AG

Inventors Hosse, Ralf; Moessner, Ekkehard; Silacci-Melkko, Michela; Umana, Pablo

Agent Griffith Hack

Pub. Number AU-A-2010285071

PCT Pub. Number WO2011/020783

Priority 61/234,584 17.08.09 US; 10162410.4 10.05.10 EP

Filing date 13 August 2010

Wipo publication date 24 February 2011

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/020783 Priority application(s): WO2011/020783

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010285082-Railway rail pad

2010285068-A nutritional composition comprising Lactococcus strains and reducing allergy symptoms, especially in infants and children.